Bay Rivers Group Amgen Inc Transaction History

Bay Rivers Group

$200 Million
Q3 2024

A detailed history of Bay Rivers Group transactions in Amgen Inc stock. As of the latest transaction made, Bay Rivers Group holds 9,675 shares of AMGN stock, worth $2.53 Million. This represents 1.56% of its overall portfolio holdings.

Number of Shares

9,675

Previous 9,651 0.25%

Holding current value

$2.53 Million

Previous $3.02 Million 3.38%

% of portfolio

1.56%

Previous 1.58%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$309.38 - $337.38 $7,425 - $8,097	24 Added 0.25%	9,675 $3.12 Million
Q2 2024 Jul 22, 2024	BUY	$262.75 - $319.31 $33,632 - $40,871	128 Added 1.34%	9,651 $3.02 Million
Q1 2024 Apr 22, 2024	BUY	$268.87 - $324.56 $6,990 - $8,438	26 Added 0.27%	9,523 $2.71 Million
Q4 2023 Jan 12, 2024	BUY	$255.7 - $288.46 $112,508 - $126,922	440 Added 4.86%	9,497 $2.74 Million
Q3 2023 Oct 05, 2023	SELL	$218.65 - $271.46 $31,704 - $39,361	-145 Reduced 1.58%	9,057 $2.43 Million
Q2 2023 Jul 13, 2023	SELL	$214.27 - $253.37 $54,210 - $64,102	-253 Reduced 2.68%	9,202 $2.04 Million
Q1 2023 Apr 18, 2023	BUY	$225.79 - $275.2 $1.04 Million - $1.26 Million	4,596 Added 94.59%	9,455 $2.29 Million
Q4 2022 Jan 17, 2023	SELL	$229.03 - $291.01 $685,257 - $870,701	-2,992 Reduced 38.11%	4,859 $0
Q3 2022 Oct 12, 2022	SELL	$224.46 - $253.15 $61,502 - $69,363	-274 Reduced 3.37%	7,851 $1.77 Million
Q2 2022 Jul 12, 2022	SELL	$230.71 - $256.74 $44,296 - $49,294	-192 Reduced 2.31%	8,125 $1.98 Million
Q1 2022 Apr 20, 2022	SELL	$219.27 - $242.57 $3,727 - $4,123	-17 Reduced 0.2%	8,317 $2.01 Million
Q4 2021 Jan 20, 2022	BUY	$198.88 - $227.6 $212,602 - $243,304	1,069 Added 14.71%	8,334 $1.88 Million
Q3 2021 Oct 13, 2021	BUY	$212.27 - $248.7 $82,360 - $96,495	388 Added 5.64%	7,265 $1.55 Million
Q2 2021 Jul 14, 2021	BUY	$233.58 - $259.14 $13,080 - $14,511	56 Added 0.82%	6,877 $1.68 Million
Q1 2021 Apr 14, 2021	BUY	$221.91 - $258.6 $41,719 - $48,616	188 Added 2.83%	6,821 $1.7 Million
Q4 2020 Jan 15, 2021	SELL	$216.38 - $257.67 $14,064 - $16,748	-65 Reduced 0.97%	6,633 $1.53 Million
Q3 2020 Oct 08, 2020	BUY	$234.65 - $260.95 $66,875 - $74,370	285 Added 4.44%	6,698 $1.7 Million
Q2 2020 Jul 09, 2020	BUY	$197.81 - $242.74 $14,637 - $17,962	74 Added 1.17%	6,413 $1.51 Million
Q1 2020 Apr 20, 2020	SELL	$182.24 - $241.7 $13,668 - $18,127	-75 Reduced 1.17%	6,339 $1.29 Million
Q4 2019 Jan 24, 2020	BUY	$189.21 - $243.2 $1.21 Million - $1.56 Million	6,414 New	6,414 $1.55 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Rivers Group, based on Form 13F filings with the SEC.

News

Stay updated on Bay Rivers Group with notifications on news.

Account